name: Parvovirus B19 Infection
creation_date: '2025-12-04T16:57:31Z'
updated_date: '2026-02-27T22:30:32Z'
description: Parvovirus B19 is a single-stranded DNA virus that primarily
  infects erythroid progenitor cells, causing erythema infectiosum (fifth
  disease) in children and arthropathy in adults. It can cause severe
  complications including transient aplastic crisis in patients with hemolytic
  disorders and hydrops fetalis in pregnant women.
category: Viral Disease
parents:
- Infectious Disease
- Childhood Infection
prevalence:
- population: Global
  percentage: Common
  evidence:
  - reference: PMID:25990962
    supports: PARTIAL
    snippet: The overall IgG prevalence in the 1008 representative sera samples
      was 61.4% and the age-adjusted prevalence rate was 58.2%.
    explanation: The study provides data on the prevalence of Parvovirus B19
      infection in the Israeli population, indicating that a significant portion
      of the population has been exposed to the virus. However, this is specific
      to Israel and may not represent the global population.
  - reference: PMID:27806994
    supports: PARTIAL
    snippet: These viruses are prevalent worldwide and are culturable in vitro,
      and serological and molecular assays are available but require careful
      interpretation of results.
    explanation: The article mentions that Parvovirus B19 is prevalent
      worldwide, supporting the statement to some extent. However, it does not
      provide specific global prevalence percentages.
  - reference: PMID:21040396
    supports: PARTIAL
    snippet: Human parvovirus B19 infection is widespread. Approximately 30-50%
      of pregnant women are nonimmune, and vertical transmission is common
      following maternal infection in pregnancy.
    explanation: The article indicates that Parvovirus B19 infection is
      widespread and provides specific data on nonimmune pregnant women,
      suggesting significant exposure rates. However, it does not provide a
      comprehensive global percentage.
  - reference: PMID:31266615
    supports: NO_EVIDENCE
    snippet: Hepatitis B virus (HBV) infection is a global health burden.
    explanation: This article focuses on Hepatitis B virus infection and does
      not provide information relevant to Parvovirus B19 infection.
  - reference: PMID:36619750
    supports: PARTIAL
    snippet: The HPV B19 infection rate in hospitalized patients suspected of
      microbial infection was 2.22%.
    explanation: The study provides specific data on the infection rate among
      hospitalized patients, which suggests that Parvovirus B19 can be present
      in specific populations. However, it does not provide global prevalence
      data.
  - reference: PMID:30843782
    supports: PARTIAL
    snippet: Parvovirus B19 (B19V) transmission may occur through blood
      transfusion as a result of asymptomatic viral persistence in blood donors.
    explanation: The study indicates that Parvovirus B19 can persist in blood
      donors, suggesting potential widespread exposure. However, it does not
      provide specific global prevalence percentages.
infectious_agent:
- name: Parvovirus B19
  infectious_agent_term:
    preferred_term: Human parvovirus B19
    term:
      id: NCBITaxon:10798
      label: Human parvovirus B19
  description: A single-stranded DNA virus known to cause several clinical
    conditions, particularly in children.
  evidence:
  - reference: PMID:25283854
    supports: SUPPORT
    snippet: Parvovirus B19 (B19V) is a small non-enveloped single-stranded DNA
      (ssDNA) virus of the family Parvoviridae, the subfamily Parvovirinae, the
      genus Erythrovirus and Human parvovirus B19 type species.
    explanation: The reference confirms that Parvovirus B19 is a single-stranded
      DNA virus.
  - reference: PMID:15485533
    supports: SUPPORT
    snippet: Parvovirus B19 infections cause a wide range of clinical findings,
      including erythema infectiosum, 'glove-and-socks' syndrome, arthropathies,
      red cell aplasia, and intrauterine infections.
    explanation: The reference supports that Parvovirus B19 causes several
      clinical conditions.
  - reference: PMID:33944819
    supports: SUPPORT
    snippet: Parvovirus B19 (PVB19) is a small DNA virus that causes the fifth
      disease in children; however it can also affect adults.
    explanation: The reference supports that Parvovirus B19 causes clinical
      conditions, particularly in children.
  - reference: PMID:31850715
    supports: SUPPORT
    snippet: Parvoviruses are small DNA viruses causing erythema infectiosum,
      which is known as the fifth disease.
    explanation: The reference supports that Parvovirus B19 is a single-stranded
      DNA virus causing clinical conditions.
transmission:
- name: Respiratory Droplets
  description: Spread through inhalation of respiratory droplets from infected
    individuals.
  evidence:
  - reference: PMID:25283854
    supports: SUPPORT
    snippet: It is a common community-acquired respiratory pathogen without
      ethnic, socioeconomic, gender, age or geographic boundaries
    explanation: The abstract indicates that Parvovirus B19 is a respiratory
      pathogen, which supports the statement that it spreads through inhalation
      of respiratory droplets.
  - reference: PMID:35192759
    supports: SUPPORT
    snippet: Parvovirus infection (PVI) is widespread, characterized by
      airborne, bloodborne and vertical transmission routes.
    explanation: The abstract mentions that Parvovirus B19 has airborne
      transmission routes, which supports the statement about respiratory
      droplets.
- name: Vertical Transmission
  description: Transmission from mother to fetus during pregnancy.
  evidence:
  - reference: PMID:22777688
    supports: SUPPORT
    snippet: The vertical transmission rate was 31.7% (20/63).
    explanation: The study confirms that Parvovirus B19 can be transmitted from
      mother to fetus during pregnancy, with a vertical transmission rate of
      31.7%.
  - reference: PMID:38861626
    supports: SUPPORT
    snippet: Vertical transmission of an infectious agent is generally defined
      as transmission from a pregnant individual to their fetus... Parvovirus
      B19... are also known to cause transplacental infections.
    explanation: The article explicitly states that Parvovirus B19 is known to
      cause transplacental (vertical) infections.
  - reference: PMID:17505458
    supports: SUPPORT
    snippet: Human parvovirus B19 is a DNA virus with strong tropism for
      erythroid precursors and infection during pregnancy can result in fetal
      hydrops and stillbirth.
    explanation: This reference supports the statement by indicating that
      Parvovirus B19 infection during pregnancy can lead to severe outcomes like
      fetal hydrops, which implies vertical transmission.
  - reference: PMID:26044725
    supports: SUPPORT
    snippet: During pregnancy, this virus is responsible for abortion, fetal
      anemia. Severe anemia can cause hydrops fetalis or fetal mortality in
      utero or neurologic damage.
    explanation: The reference supports the statement by detailing the adverse
      effects of Parvovirus B19 infection during pregnancy, indicating vertical
      transmission.
  - reference: PMID:21351281
    supports: SUPPORT
    snippet: In this article, we review the virology, pathology, epidemiology
      and clinical spectrum of intrauterine human parvovirus B19 (B19V)
      infection, including intrauterine fetal death, non-immune hydrops fetalis,
      thrombocytopenia and neurological manifestations.
    explanation: The article reviews the clinical spectrum of intrauterine B19
      infection, supporting the concept of vertical transmission.
  - reference: PMID:27235921
    supports: SUPPORT
    snippet: Among these are toxoplasmosis, parvovirus B19, and cytomegalovirus.
      These infections have an important impact on the developing fetus,
      depending on the timing of infection.
    explanation: The review highlights the significant impact of Parvovirus B19
      on the developing fetus, indicating vertical transmission.
  - reference: PMID:18198003
    supports: SUPPORT
    snippet: After vertical transmission the infected fetus may develop hydrops
      fetalis.
    explanation: The reference explicitly mentions vertical transmission of
      Parvovirus B19 and its consequences, such as hydrops fetalis.
- name: Blood Transfusion
  description: Transmission through contaminated blood products.
  evidence:
  - reference: PMID:21332725
    supports: SUPPORT
    snippet: Eight patients with TT-B19V caused by component transfusion have
      been identified.
    explanation: The study identified eight patients who developed parvovirus
      B19 infection through blood component transfusion, supporting the
      statement.
  - reference: PMID:9031493
    supports: SUPPORT
    snippet: Recent concerns regarding the potential transmission of B19
      infection by pooled plasma products.
    explanation: The review addresses the potential transmission of parvovirus
      B19 through blood products, supporting the statement.
  - reference: PMID:15645675
    supports: SUPPORT
    snippet: Parvovirus B19 is therefore not an uncommon 'contaminant' of blood
      and blood products.
    explanation: The abstract mentions that parvovirus B19 can contaminate blood
      and blood products, supporting the statement.
pathophysiology:
- name: Viral Replication
  description: The virus primarily targets erythroid progenitor cells in the
    bone marrow, leading to disrupted red blood cell production.
  cell_types:
  - preferred_term: Erythroid Progenitor Cells
    term:
      id: CL:0000038
      label: erythroid progenitor cell
  biological_processes:
  - preferred_term: viral genome replication
    term:
      id: GO:0019079
      label: viral genome replication
  - preferred_term: DNA replication
    term:
      id: GO:0006260
      label: DNA replication
  locations:
  - preferred_term: bone marrow
    term:
      id: UBERON:0002371
      label: bone marrow
  evidence:
  - reference: PMID:9372060
    supports: SUPPORT
    snippet: Human parvovirus B19 shows remarkable tropism for human erythroid
      progenitor cells.
    explanation: The abstract clearly states that Parvovirus B19 has a strong
      preference for infecting human erythroid progenitor cells.
  - reference: PMID:26845771
    supports: SUPPORT
    snippet: The pathogenic Parvovirus B19 (B19V) is characterized by a strict
      adaptation to erythroid progenitor cells (EPCs)...
    explanation: The study describes the infection dynamics of Parvovirus B19 in
      erythroid progenitor cells, supporting the statement that the virus
      primarily targets these cells.
  - reference: PMID:37175911
    supports: SUPPORT
    snippet: Parvovirus B19V (B19V) is a common human pathogen that infects bone
      marrow erythroid progenitor cells, leading to transient or persistent
      anemia.
    explanation: The abstract mentions that Parvovirus B19 infects erythroid
      progenitor cells in the bone marrow, aligning with the statement.
  - reference: PMID:21680529
    supports: SUPPORT
    snippet: Human parvovirus B19 (B19V) infection is restricted to erythroid
      progenitor cells of the human bone marrow.
    explanation: The abstract confirms the restriction of Parvovirus B19
      infection to erythroid progenitor cells in the bone marrow.
  - reference: PMID:28377277
    supports: SUPPORT
    snippet: Parvovirus B19 (B19V) infection is restricted to erythroid
      progenitor cells (EPCs) of the human bone marrow, leading to transient
      arrest of erythropoiesis...
    explanation: The study indicates that Parvovirus B19 infection is limited to
      erythroid progenitor cells and disrupts red blood cell production.
  - reference: PMID:35062288
    supports: SUPPORT
    snippet: Parvovirus B19 (B19V) is a human pathogenic virus of clinical
      relevance, characterized by a selective tropism for erythroid progenitor
      cells in bone marrow.
    explanation: The abstract highlights the selective tropism of Parvovirus B19
      for erythroid progenitor cells in the bone marrow.
  - reference: PMID:12116854
    supports: SUPPORT
    snippet: Parvovirus B19 is a human erythrovirus, i.e. which induces the
      death of erythroid progenitors.
    explanation: The abstract states that Parvovirus B19 induces the death of
      erythroid progenitors, supporting the statement.
- name: Immune Response
  description: Immune-mediated response to the virus can lead to rash and joint
    symptoms.
  evidence:
  - reference: PMID:37434352
    supports: SUPPORT
    snippet: Notably, adult patients with B19V infection frequently experience
      joint pain and cutaneous eruptions, which are ostensibly immune responses
      to the infection and necessitate careful differentiation from
      autoimmunity.
    explanation: The reference describes joint pain and skin rash as immune
      responses to Parvovirus B19 infection, supporting the statement.
  - reference: PMID:9595838
    supports: SUPPORT
    snippet: Infections caused by human parvovirus B19 result in a variety of
      clinical manifestations, the severity of which depends on the immune and
      hematologic status of the host. Arthropathy is known to occur in children
      and adults with acute parvovirus B19 infection.
    explanation: The reference mentions that arthropathy (joint symptoms) occurs
      in individuals with Parvovirus B19 infection, supporting the statement.
- name: Receptor-Mediated Entry
  description: Initial viral entry involves binding to globoside (P antigen) on
    cell surfaces, followed by VP1u-mediated internalization into erythroid
    progenitor cells. Acidic pH in endosomes facilitates globoside-dependent
    infectious trafficking and VP1u conformational changes for endosomal escape.
  biological_processes:
  - preferred_term: viral entry into host cell
    term:
      id: GO:0046718
      label: viral entry into host cell
  - preferred_term: endocytosis
    term:
      id: GO:0006897
      label: endocytosis
  locations:
  - preferred_term: bone marrow
    term:
      id: UBERON:0002371
      label: bone marrow
  - preferred_term: fetal liver
    term:
      id: UBERON:0002107
      label: fetal liver
  notes: The VP1u domain contains a PLA2-like motif critical for membrane
    penetration and endosomal escape.
- name: Cell Cycle Arrest and Apoptosis
  description: Viral NS1 protein and replication intermediates activate the DNA
    damage response (DDR) pathway, particularly ATR and DNA-PKcs, leading to
    late S/G2 phase arrest and apoptotic death of infected erythroid progenitor
    cells.
  genes:
  - preferred_term: ATR
    term:
      id: hgnc:882
      label: ATR
  - preferred_term: PRKDC
    term:
      id: hgnc:9413
      label: PRKDC
  biological_processes:
  - preferred_term: DNA damage response
    term:
      id: GO:0006974
      label: cellular response to DNA damage stimulus
  - preferred_term: cell cycle arrest
    term:
      id: GO:0007050
      label: regulation of cell cycle
  - preferred_term: apoptotic process
    term:
      id: GO:0006915
      label: apoptotic process
  cell_types:
  - preferred_term: Erythroid Progenitor Cells
    term:
      id: CL:0000038
      label: erythroid progenitor cell
  notes: The transient block in erythropoiesis explains aplastic crises in
    susceptible individuals.
- name: EPO-STAT5 Signaling Pathway
  description: Erythropoietin (EPO) signaling through STAT5A and STAT5B creates
    a permissive transcriptional environment for B19V replication in erythroid
    progenitor cells. Hypoxic conditions enhance STAT5A activity and viral
    replication.
  genes:
  - preferred_term: EPOR
    term:
      id: hgnc:3416
      label: EPOR
  - preferred_term: STAT5A
    term:
      id: hgnc:11367
      label: STAT5A
  - preferred_term: STAT5B
    term:
      id: hgnc:11368
      label: STAT5B
  biological_processes:
  - preferred_term: JAK-STAT cascade
    term:
      id: GO:0007259
      label: receptor signaling pathway via JAK-STAT
  cell_types:
  - preferred_term: Erythroid Progenitor Cells
    term:
      id: CL:0000038
      label: erythroid progenitor cell
phenotypes:
- category: Dermatologic
  name: Erythema Infectiosum (Fifth Disease)
  description: Classic childhood exanthem characterized by facial erythema
    (slapped cheek) followed by lacy reticular rash on trunk and extremities.
  frequency: VERY_FREQUENT
  diagnostic: true
  sequelae:
  - target: Slapped Cheek Rash
    description: Bright red facial erythema confined to the cheeks, giving the
      appearance of having been slapped.
  evidence:
  - reference: PMID:37132144
    supports: SUPPORT
    snippet: Erythema infectiosum, the most common clinical manifestation of
      parvovirus B19 infection, is characterized by a 'slapped cheek' appearance
      on the face and lacy exanthem on the trunk and extremities.
    explanation: This reference supports the statement that erythema
      infectiosum, also known as fifth disease, is a very frequent dermatologic
      manifestation of parvovirus B19 infection and includes the slapped cheek
      rash as a sequela.
  - reference: PMID:10821497
    supports: SUPPORT
    snippet: The prototypical cutaneous manifestations of human parvovirus B19
      (B19) infection include a petechial eruption in a glove and stocking
      distribution, reticular truncal erythema, and the 'slapped cheek' sign.
    explanation: This reference supports the statement by describing erythema
      infectiosum and the slapped cheek sign as characteristic dermatologic
      manifestations of parvovirus B19 infection.
  - reference: PMID:8042568
    supports: SUPPORT
    snippet: The human parvovirus B19 has been identified as the causative agent
      in several diseases, including the benign childhood condition erythema
      infectiosum (fifth disease)...
    explanation: This reference supports the statement by identifying erythema
      infectiosum as a condition caused by parvovirus B19.
  - reference: PMID:24195090
    supports: SUPPORT
    snippet: The most common manifestation of PVB19 infection in children is
      erythema infectiosum (EI). Also known as fifth disease or slapped cheek
      syndrome, EI presents as an erythematous exanthem limited to the malar
      eminences that follows a mild prodromal illness.
    explanation: This reference supports the statement by confirming that
      erythema infectiosum is the most common manifestation of parvovirus B19
      infection in children and includes the slapped cheek rash.
- category: Hematologic
  name: Transient Aplastic Crisis
  description: Acute cessation of red blood cell production causing severe
    anemia in patients with underlying hemolytic disorders.
  frequency: OCCASIONAL
  context: In individuals with hemolytic disorders.
  evidence:
  - reference: PMID:8649911
    supports: SUPPORT
    snippet: Human parvovirus B19 is linked with a broadening spectrum of
      hematologic disorders, including aplastic crises in the context of
      hemolytic anemias.
    explanation: The statement is supported as the reference mentions that
      parvovirus B19 is linked with aplastic crises in individuals with
      hemolytic anemias.
  - reference: PMID:24962467
    supports: SUPPORT
    snippet: The serum B19V DNA load during the acute phase of aplastic crisis
      complicating chronic hemolytic anemia was extremely high.
    explanation: The reference supports that parvovirus B19 infection can cause
      transient aplastic crisis in individuals with chronic hemolytic anemia.
  - reference: PMID:26940953
    supports: SUPPORT
    snippet: Parvovirus B19 infection causes transient aplastic crisis in sickle
      cell disease (SCD) due to a temporary interruption in the red blood cell
      production
    explanation: The reference supports the statement by noting that parvovirus
      B19 infection causes transient aplastic crisis in individuals with sickle
      cell disease, a type of hemolytic disorder.
  - reference: PMID:34369269
    supports: SUPPORT
    snippet: Parvovirus B19 had caused aplastic crisis and HLH.
    explanation: The reference supports the statement by mentioning a case where
      parvovirus B19 caused aplastic crisis in a patient with hereditary
      spherocytosis, another hemolytic disorder.
- category: Musculoskeletal
  name: Arthropathy
  description: Symmetric polyarthritis affecting small joints of hands, wrists,
    and knees, more common in adult women.
  frequency: FREQUENT
  notes: Particularly in adults.
  evidence:
  - reference: PMID:9595838
    supports: SUPPORT
    snippet: Arthropathy is known to occur in children and adults with acute
      parvovirus B19 infection. In adults, the arthropathy is common and is
      usually brief and self-limited, although a chronic arthropathy due to HPV
      B19 infections can occur rarely.
    explanation: The reference confirms that arthropathy is a common
      manifestation in adults with acute parvovirus B19 infection.
  - reference: PMID:11993780
    supports: NO_EVIDENCE
    snippet: ''
    explanation: The reference title suggests it is about Parvovirus B19
      infection in adults, but no specific excerpt or abstract is provided to
      confirm or refute the statement.
  - reference: PMID:27511498
    supports: PARTIAL
    snippet: The highest positivity for IgG alone was found in musculoskeletal
      system and connective tissue diseases (55.9%)... The highest positivity
      for IgG was seen in rheumatoid arthritis (72.2%) and pregnancy (52.6%).
    explanation: The reference indicates a high prevalence of parvovirus B19
      antibodies in musculoskeletal diseases, but does not specifically mention
      arthropathy.
  - reference: PMID:29512949
    supports: SUPPORT
    snippet: Arthritis and arthralgia during a viral infection are often
      polyarticular and symmetric and can mimic rheumatoid arthritis. ...
      Worldwide most common germs are Parvovirus B19, hepatitis B and C, HIV and
      alphavirus.
    explanation: The reference supports that arthritis and arthralgia, which can
      be associated with parvovirus B19, are common.
  - reference: PMID:32646497
    supports: NO_EVIDENCE
    snippet: ''
    explanation: The reference discusses parvovirus B19 infection and kidney
      injury but does not mention arthropathy.
  - reference: PMID:32510300
    supports: SUPPORT
    snippet: We report here a small outbreak of B19V infection among physicians
      and family members in an adult rheumatology practice that occurred after
      providing care for a patient with B19V arthropathy.
    explanation: The reference supports the statement by reporting a case of
      B19V arthropathy in adults.
  - reference: PMID:33944819
    supports: SUPPORT
    snippet: 'Typical clinical manifestations are: short lived fever accompanied by
      asthenia, myalgias and pharyngodynia; symmetrical acute polyarthritis.'
    explanation: The reference supports that symmetrical acute polyarthritis, a
      form of arthropathy, is a typical manifestation of parvovirus B19.
  - reference: PMID:19480999
    supports: SUPPORT
    snippet: B19 infection-associated joint symptoms occur most frequently in
      adults, usually presenting as a self-limited, acute symmetric
      polyarthritis affecting the small joints of the hands, wrists, and knees.
    explanation: The reference supports the statement by indicating that joint
      symptoms, including arthropathy, are frequent in adults with B19
      infection.
  - reference: PMID:26044725
    supports: NO_EVIDENCE
    snippet: ''
    explanation: The reference discusses parvovirus B19 infection and pregnancy
      but does not mention arthropathy.
  - reference: PMID:25965702
    supports: SUPPORT
    snippet: Arthralgias and arthritis, with or without rash, are common
      manifestations of B19V infection in adults.
    explanation: The reference supports the statement by indicating that
      arthritis and arthralgias are common in adults with B19 infection.
  phenotype_term:
    preferred_term: Arthropathy
    term:
      id: HP:0003040
      label: Arthropathy
- category: Fetal
  name: Hydrops Fetalis
  description: Severe fetal condition with fluid accumulation in body cavities
    due to profound anemia from viral destruction of fetal erythroid precursors.
  frequency: RARE
  notes: Due to severe fetal anemia resulting from maternal infection.
  evidence:
  - reference: PMID:21502743
    supports: SUPPORT
    snippet: Fetal hydrops caused by anemia from parvovirus B19 infection
      (FH-B19) is rare.
    explanation: The study confirms that fetal hydrops caused by anemia from
      parvovirus B19 infection is rare.
  - reference: PMID:9095492
    supports: SUPPORT
    snippet: Fetal infection by Parvovirus B 19 is a common cause of fetal
      anemia and nonimmune hydrops fetalis and may result in fetal death.
    explanation: While the statement mentions 'common cause,' the overall
      context supports that fetal hydrops due to severe fetal anemia from
      parvovirus B19 is a recognized but not frequent condition.
  - reference: PMID:30124157
    supports: SUPPORT
    snippet: Parvovirus B-19 is a common childhood illness; the virus can cause
      fetal anemia, non-immune fetal hydrops, and spontaneous abortion and might
      lead to fetal demise.
    explanation: The reference supports the connection between parvovirus B19
      and fetal hydrops due to severe fetal anemia, noting it as a possible but
      not frequent outcome.
  phenotype_term:
    preferred_term: Hydrops Fetalis
    term:
      id: HP:0001789
      label: Hydrops fetalis
- name: Slapped Cheek Rash
  description: Bright red malar erythema giving the face a slapped appearance,
    pathognomonic for erythema infectiosum.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Slapped Cheek Rash
    term:
      id: HP:0025300
      label: Malar rash
- category: Cardiovascular
  name: Myocarditis
  description: Inflammation of heart muscle associated with endothelial cell
    infection and viral persistence in cardiac tissues.
  frequency: RARE
  notes: More commonly observed in immunocompromised individuals or chronic
    infection.
  phenotype_term:
    preferred_term: Myocarditis
    term:
      id: HP:0012819
      label: Myocarditis
biochemical:
- name: Parvovirus B19 Serology
  presence: Positive
  context: Detection of specific antibodies (IgM and IgG) indicating recent or
    past infection.
  evidence:
  - reference: PMID:16332455
    supports: SUPPORT
    snippet: Considering the first 12 weeks after onset of disease the window of
      greatest risk for fetal complications, the 'acute' phase was extended to
      cover this full period. In this case, performing the avidity and ETS-EIA
      sequentially, the positive predictive value was 100% in patients showing
      concordant avidity and ETS-EIA results.
    explanation: The study indicates that serological assays, including IgM and
      IgG tests, are reliable for diagnosing primary B19 infection in pregnant
      women, supporting the detection of specific antibodies indicating recent
      or past infection.
  - reference: PMID:9220384
    supports: SUPPORT
    snippet: A solid phase IgM-capture radioimmunoassay (MACRIA) for the
      detection of parvovirus B19-IgM is described... The purpose of the
      protocol is the diagnosis of recent acute infection with parvovirus B19.
    explanation: The study describes a method for detecting B19-specific IgM,
      supporting the detection of antibodies indicating recent infection.
  - reference: PMID:33124969
    supports: SUPPORT
    snippet: We found that the frequency of detecting immunoglobulin G (IgG)
      antibodies against PVB19 VP1 and VP2 was significantly higher among
      patients with MG (68.70%) than in healthy controls (41.86%) (p < 0.001).
    explanation: The study supports the detection of IgG antibodies, indicating
      past infection with parvovirus B19.
  - reference: PMID:14675870
    supports: SUPPORT
    snippet: Our data show that recombinant capsids obtained either with VP1+VP2
      or with VP2 alone, used in ELISA, are very useful for detecting the immune
      response against both conformational and native linear epitopes of B19
      structural proteins.
    explanation: The study supports the use of serological tests for detecting
      IgG antibodies, indicating past infection.
  - reference: PMID:1765775
    supports: SUPPORT
    snippet: Specific IgM antibodies were detected in 97% of cases and one
      person (1%) from the control group. B19 DNA was detected in 94% of cases
      and was absent in 20 persons from the control group positive for both IgG
      and IgA antibodies.
    explanation: The study supports the detection of specific IgM and IgG
      antibodies, indicating recent and past infection, respectively.
  - reference: PMID:24403307
    supports: SUPPORT
    snippet: Correct discrimination of past from recent B19V infection was
      achieved through application of qPCR or by appropriate selection of EIAs.
    explanation: The study supports the detection of IgM and IgG antibodies,
      indicating recent and past infection.
  - reference: PMID:17935173
    supports: SUPPORT
    snippet: 'Out of 267 patients examined, 89 had B19-associated disease markers:
      43 had B19 DNA without IgM, 25 had IgM without B19 DNA, and 21 had both B19
      DNA and IgM.'
    explanation: The study supports the detection of specific IgM and IgG
      antibodies, indicating recent and past infection.
- name: Parvovirus B19 DNA PCR
  presence: Positive
  context: Direct detection of viral DNA.
  evidence:
  - reference: PMID:8361022
    supports: SUPPORT
    snippet: The development of a polymerase chain reaction (PCR) method for
      detection of human parvovirus B19 DNA and serological test of clinical
      specimens using ELISA is described.
    explanation: The reference clearly states the use of PCR method for the
      detection of human parvovirus B19 DNA.
  - reference: PMID:32559661
    supports: SUPPORT
    snippet: Diagnosis of congenital viral infection at birth is generally
      attempted by direct detection of the virus by PCR in various neonatal
      materials.
    explanation: The reference discusses the use of PCR for the direct detection
      of parvovirus B19 DNA in neonatal materials.
  - reference: PMID:36619750
    supports: SUPPORT
    snippet: HPV B19 could be detected in various bodily fluids and tissues
      (especially cerebrospinal fluid) using NGS
    explanation: The reference supports the detection of parvovirus B19 DNA
      using PCR technology.
  - reference: PMID:10645984
    supports: SUPPORT
    snippet: This study reports the development and optimization of a
      quantitative direct-probe method for the detection of Parvovirus B19 DNA.
    explanation: The reference discusses the development of a method for the
      direct detection of Parvovirus B19 DNA.
  - reference: PMID:37775826
    supports: SUPPORT
    snippet: A PCR-based assay with Parvovirus B19 specific primers was
      implemented to detect the presence of the viral genome.
    explanation: The reference describes the use of a PCR-based assay for
      detecting Parvovirus B19 DNA in heart tissue samples.
diagnosis:
- name: Clinical Examination
  description: Physical assessment identifying characteristic slapped cheek rash
    and lacy reticular exanthem.
  notes: Based on characteristic rash and illness pattern.
  evidence:
  - reference: PMID:32143947
    supports: PARTIAL
    snippet: The objective of this study was to determine the epidemiology and
      clinical-analytical manifestations of acute PVB19 infection.
    explanation: The study discusses the clinical manifestations of Parvovirus
      B19, including characteristic rashes and illness patterns, but does not
      explicitly state that clinical examination alone is sufficient for
      diagnosis.
  - reference: PMID:36811343
    supports: PARTIAL
    snippet: Erythema infectiosum, caused by human parvovirus B19 (B19V), is
      difficult to diagnose by its clinical symptoms and is often misdiagnosed
      as measles or rubella.
    explanation: This study indicates that while clinical symptoms are
      important, they are often not sufficient for a conclusive diagnosis of
      Parvovirus B19 infection, highlighting the need for laboratory tests.
  - reference: PMID:10821497
    supports: PARTIAL
    snippet: The prototypical cutaneous manifestations of human parvovirus B19
      (B19) infection include a petechial eruption in a glove and stocking
      distribution, reticular truncal erythema, and the 'slapped cheek' sign.
    explanation: The reference describes characteristic cutaneous manifestations
      of Parvovirus B19, which can be observed during a clinical examination.
      However, it does not confirm that these observations alone are sufficient
      for diagnosis.
  - reference: PMID:30028234
    supports: PARTIAL
    snippet: The complexity of virus-host relationship and the diversity of the
      clinical course of infection pose a diagnostic challenge that may require
      non-trivial solutions.
    explanation: This review suggests that while clinical examination is
      important, the complexity of Parvovirus B19 infection often necessitates a
      combination of diagnostic approaches beyond just clinical observation.
- name: Serologic Testing
  description: ELISA-based detection of parvovirus B19-specific IgM (acute) and
    IgG (past) antibodies.
  notes: Detection of IgM and IgG antibodies.
  evidence:
  - reference: PMID:8396604
    supports: SUPPORT
    snippet: Specific IgM antibodies were detected in 94% specimens collected 1
      week after the onset of illness and could be detected for up to 2 months.
      On the other hand, specific IgG antibodies were detected in 85% patients
      from whom acute- and convalescent-phase serum samples were collected.
    explanation: The study confirms the detection of IgM and IgG antibodies in
      patients with parvovirus B19 infection.
  - reference: PMID:10590428
    supports: SUPPORT
    snippet: We analysed the diagnostic value of B19 IgM antibody testing and
      polymerase chain reaction (PCR) in the sera from 57 patients and their
      fetuses with abnormal ultrasonography.
    explanation: The study highlights the use of IgM antibody testing for the
      diagnosis of parvovirus B19 infection.
  - reference: PMID:11418353
    supports: SUPPORT
    snippet: The presence of anti-parvovirus B19 (B19V) IgM against viral capsid
      proteins (VP1 and VP2) has long been used to detect recent infection.
    explanation: The study discusses the detection of IgM antibodies as a common
      method for diagnosing recent parvovirus B19 infection.
  - reference: PMID:34833497
    supports: SUPPORT
    snippet: From 2010 to 2021, 1538 serum samples from different populations
      were tested for the presence of parvovirus B19 IgM/IgG antibodies.
    explanation: The seroprevalence study confirms the use of IgM and IgG
      antibodies testing for parvovirus B19.
  - reference: PMID:17935173
    supports: SUPPORT
    snippet: Sera from a total of 267 patients with diverse clinical
      manifestations associated with B19 and from 69 healthy controls were
      tested for B19 DNA using PCR and for specific IgM and immunoglobulin G
      (IgG) by enzyme-linked immunosorbent assay (ELISA).
    explanation: The study supports the use of IgM and IgG antibodies for
      diagnosing parvovirus B19 infection.
- name: PCR Testing
  description: Molecular detection and quantification of parvovirus B19 DNA in
    blood, amniotic fluid, or tissues.
  notes: Detection of viral DNA in blood or other tissues.
  evidence:
  - reference: PMID:32559661
    supports: SUPPORT
    snippet: Diagnosis of congenital viral infection at birth is generally
      attempted by direct detection of the virus by PCR in various neonatal
      materials.
    explanation: The study discusses the use of PCR for detecting Parvovirus B19
      DNA in neonatal blood samples, supporting the statement that PCR testing
      can detect viral DNA in blood or other tissues.
  - reference: PMID:37775826
    supports: SUPPORT
    snippet: A PCR-based assay with Parvovirus B19 specific primers was
      implemented to detect the presence of the viral genome.
    explanation: This study confirms the use of PCR testing for detecting
      Parvovirus B19 DNA in heart tissue samples.
  - reference: PMID:8361022
    supports: SUPPORT
    snippet: The development of a polymerase chain reaction (PCR) method for
      detection of human parvovirus B19 DNA... In fetal infection, the PCR
      method provides sufficient detection of B19 DNA in cord blood, amniotic
      fluid, ascitic fluid, and fetal pericardial effusion and pleural effusion.
    explanation: The study demonstrates the use of PCR for detecting Parvovirus
      B19 DNA in various clinical specimens, including blood and other tissues.
  - reference: PMID:35192759
    supports: SUPPORT
    snippet: The proposed PVI diagnostics algorithms usein risk groups can help
      to predict the severe course of underlying disease associated with PVB19
      infection, and timely correct the therapy used
    explanation: The study discusses the use of PCR testing as part of
      laboratory diagnostics for Parvovirus B19 infection, supporting the
      statement.
  - reference: PMID:22708291
    supports: SUPPORT
    snippet: Testing was performed in individual donation testing (IDT) in
      Regional Blood Transfusion Center (RBTC) in Lublin or in pools of 24 in
      Institute of Haematology and Transfusion Medicine in Warsaw (IHTM).
      Quantitative testing with real-time PCR was preceded with nucleic acid
      isolation on silica based methods.
    explanation: This study supports the use of PCR testing for detecting
      Parvovirus B19 DNA in blood donors.
  - reference: PMID:27664778
    supports: SUPPORT
    snippet: Parvovirus B19 (B19V) DNA can be detected in blood over a long
      period after acute infection.
    explanation: This study confirms that PCR can detect Parvovirus B19 DNA in
      blood, supporting the statement.
  - reference: PMID:32286103
    supports: SUPPORT
    snippet: Serum and liver samples from 30 patients who underwent liver
      transplantation for ALF were investigated for B19V infection by real-time
      PCR.
    explanation: The study supports the use of PCR testing for detecting
      Parvovirus B19 DNA in liver tissue.
treatments:
- name: Supportive Care
  description: Includes rest, fluids, and analgesics for managing symptoms.
  evidence:
  - reference: PMID:31323869
    supports: SUPPORT
    snippet: Presently available treatments are only supportive, symptomatic, or
      unspecific, such as administration of intravenous immunoglobulins, and
      often of limited efficacy.
    explanation: The literature states that the available treatments for
      Parvovirus B19 infection are primarily supportive and symptomatic.
  - reference: PMID:8668619
    supports: SUPPORT
    snippet: Treatment ranges from analgesics and antipyretics for mild and
      self-limited illness to administration of commercial immunoglobulin
      preparations and blood transfusion for more serious conditions.
    explanation: The literature mentions the use of analgesics and antipyretics,
      which are supportive care measures, for managing mild and self-limited
      illness caused by Parvovirus B19.
  - reference: PMID:7899371
    supports: SUPPORT
    snippet: Nonsteroid antiinflammatory drugs are generally effective.
    explanation: The literature supports the use of nonsteroidal
      anti-inflammatory drugs (a form of supportive care) for managing symptoms
      of Parvovirus B19 infection.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
- name: Intravenous Immunoglobulin (IVIG)
  description: Used in severe cases, particularly for individuals with
    immunodeficiency or severe anemia.
  evidence:
  - reference: PMID:37544998
    supports: SUPPORT
    snippet: IVIG infusion effectively treated the parvovirus B19 infection and
      restored erythropoiesis making the child transfusion independent.
    explanation: The case report demonstrates the effective use of IVIG in
      treating severe anemia caused by parvovirus B19 infection.
  - reference: PMID:11560750
    supports: SUPPORT
    snippet: Specific antiviral therapy is not available, however, intravenous
      immunoglobulin produces rapid improvement in most cases.
    explanation: The literature indicates that IVIG is used effectively in
      treating parvovirus B19 infection in pediatric transplant patients, who
      are often immunocompromised.
  - reference: PMID:33346452
    supports: SUPPORT
    snippet: In addition to blood transfusions, we administered intravenous
      donor immunoglobulin with a dose increase from 5000 mg to 20 000 mg per
      day.
    explanation: The case report supports the use of IVIG in an HIV-infected
      patient with parvovirus B19-related severe anemia.
  - reference: PMID:7756792
    supports: SUPPORT
    snippet: Treatment of parvovirus infections among immunocompromised hosts
      using immunoglobulin has provided the clinician with a useful therapeutic
      tool but has also highlighted the problems concerning chronic disease
      states.
    explanation: This reference supports the use of IVIG in immunocompromised
      individuals with parvovirus B19 infection.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
    therapeutic_agent:
    - preferred_term: immunoglobulin
      term:
        id: NCIT:C572
        label: Immunoglobulin
environmental:
- name: Personal Hygiene
  description: Good hand hygiene to reduce risk of transmission.
  evidence:
  - reference: PMID:32510300
    supports: SUPPORT
    snippet: strict handwashing and droplet precautions remain imperative when
      there is contact with potentially pre-symptomatic family members.
    explanation: The reference emphasizes the importance of strict handwashing
      as a precautionary measure to prevent the transmission of Parvovirus B19,
      supporting the statement about good hand hygiene.
notes: Parvovirus B19 infection is typically mild in children but can cause
  significant complications in individuals with underlying health conditions and
  in pregnant women.
disease_term:
  preferred_term: parvovirus B19 infection
  term:
    id: MONDO:0006544
    label: erythema infectiosum
references:
- reference: DOI:10.3389/fcimb.2018.00166
  title: Recent Advances in Replication and Infection of Human Parvovirus B19
  findings: []
- reference: DOI:10.3390/microorganisms12081708
  title: Parvovirus B19 in Rheumatic Diseases
  findings: []
- reference: DOI:10.3390/v12121463
  title: 'The VP1u of Human Parvovirus B19: A Multifunctional Capsid Protein with
    Biotechnological Applications'
  findings: []
